Baxalta Bioscience India

Takeda, formerly operating as Baxalta Bioscience India, is a global biopharmaceutical leader with a significant presence in the Indian healthcare market. The company specializes in developing and delivering innovative treatments for rare diseases, particularly in the fields of hematology, immunology, and oncology. Its portfolio includes market-leading products such as Advate and Adynovate for hemophilia, as well as specialized immunoglobulin therapies for primary immunodeficiency. Following the acquisition of Baxalta by Shire and the subsequent acquisition of Shire by Takeda, the company has integrated its operations to provide a broader range of therapeutic solutions. Takeda India focuses on improving patient access to life-saving medicines through strategic partnerships and a robust distribution network. The organization remains committed to addressing high unmet medical needs in the region through its diverse pipeline and commercialized biologics.